Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of iridium catalyzed moxifloxacin side chain intermediate

A moxifloxacin side chain and intermediate technology, applied in the field of pharmaceuticals, can solve problems such as environmental pollution, reduce the total synthesis yield, increase production costs, etc., and achieve the effect of wide application prospects

Active Publication Date: 2018-10-09
XINXIANG UNIV
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] Looking at the synthetic routes of the moxifloxacin side chains that have been developed, we can find that the main problem in the known routes is that they all adopt a non-asymmetric method to first obtain a pair of enantiomers, and then obtain the whole compound by chiral resolution. the desired isomer, while its enantiomer becomes waste in these synthetic routes
The generation of these wastes not only greatly reduces the overall yield of synthesis, but also requires additional chiral resolution steps to obtain the desired isomers, which greatly affects the efficiency of synthesis and increases production costs.
At the same time, these wastes will also bring certain pollution to the environment.
Therefore, the known synthetic routes of the side chains of moxifloxacin do not meet the requirements of green chemistry

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of iridium catalyzed moxifloxacin side chain intermediate
  • Preparation method of iridium catalyzed moxifloxacin side chain intermediate
  • Preparation method of iridium catalyzed moxifloxacin side chain intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Asymmetric hydrogenation of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4,3,0]nonane: In a 10mL reaction tube, add Phosphine ligand L1 (0.005mmol) and [Ir(COD)Cl] 2 (0.005mmol), the system passed through the vacuum line, replaced with nitrogen for 3 times, added 2 mL of freshly steamed degassed toluene, the solution was stirred at room temperature for 1 hour, and the solvent was removed under reduced pressure to obtain a brown solid. After 2 hours of vacuum pumping, 2 mL of tert-butanol solvent, add this solution into a vial containing 6-benzyl-pyrrolo[3,4-b]pyridine-5,7-dione (0.5mmol), put it into an autoclave and replace it with hydrogen six times Afterwards, the initial hydrogen pressure was 20 bar, and the reaction was stirred at 90° C. for 24 hours. Cool, release gas carefully, open the autoclave, take out the vial, drain the solvent, detect the conversion rate by NMR, detect the enantiomeric excess value by liquid chromatography, and obtain the product by column...

Embodiment 2

[0038] Asymmetric hydrogenation of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4,3,0]nonane: In a 10mL reaction tube, add Phosphine ligand L1 (0.005mmol) and [Ir(COD)Cl] 2 (0.005mmol), the system passed through the vacuum line, replaced 3 times with nitrogen, added 2 mL of freshly steamed degassed tert-butanol, and the solution was stirred at room temperature for 1 hour, and the solvent was removed under reduced pressure to obtain a brown solid. After vacuum pumping for 2 hours, Add 2mL of tert-butanol solvent, add this solution into a vial containing 6-benzyl-pyrrolo[3,4-b]pyridine-5,7-dione (0.5mmol), and put it into an autoclave for six times After hydrogen replacement, the initial hydrogen pressure was 20 bar, and the reaction was stirred at 90° C. for 24 hours. Cool, release gas carefully, open the autoclave, take out the vial, drain the solvent, detect the conversion rate by NMR, detect the enantiomeric excess value by liquid chromatography, and obtain the product by co...

Embodiment 3

[0040] Asymmetric hydrogenation of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4,3,0]nonane: In a 10mL reaction tube, add Phosphine ligand L2 (0.005mmol) and [Ir(COD)Cl] 2 (0.005mmol), the system passed through the vacuum line, replaced 3 times with nitrogen, added 2 mL of freshly steamed degassed tert-butanol, and the solution was stirred at room temperature for 1 hour, and the solvent was removed under reduced pressure to obtain a brown solid. After vacuum pumping for 2 hours, Add 2mL of tert-butanol solvent, add this solution into a vial containing 6-benzyl-pyrrolo[3,4-b]pyridine-5,7-dione (0.5mmol), and put it into an autoclave for six times After hydrogen replacement, the initial hydrogen pressure was 20 bar, and the reaction was stirred at 90° C. for 24 hours. Cool, release gas carefully, open the autoclave, take out the vial, drain the solvent, detect the conversion rate by NMR, detect the enantiomeric excess value by liquid chromatography, and obtain the product by co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of an iridium catalyzed moxifloxacin side chain intermediate. The preparation method of the iridium catalyzed moxifloxacin side chain intermediate comprises the following step: under the catalysis of a chiral catalyst, carrying out an asymmetric hydrogenation reaction between 6-benzyl-pyrrolo[3,4-b]pyridine-5,7-diketone and hydrogen in an organic solvent to obtain (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazo heterocyclic ring[4,3,0]nonane. The preparation method has the advantages of high efficiency, high universality on substrates and high enantioselectivity, and has wide application prospect in the fields of asymmetric synthesis and pharmaceutical research and development.

Description

technical field [0001] The invention belongs to the field of pharmacy, in particular to a moxifloxacin side chain intermediate (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4,3, 0] Preparation method of nonane. Background technique [0002] Moxifloxacin hydrochloride is the fourth generation of extended-spectrum quinolones developed by Bayer in Germany in 1999. For example, Mycoplasma, Chlamydia and Legionella have broad-spectrum antibacterial activity, strong antibacterial activity, broad antibacterial spectrum, are not easy to produce drug resistance, are effective against common drug-resistant bacteria, have long half-life and few adverse reactions. (Jiang Zhongya, Jin Yuxiang. Clinical analysis of 40 cases of respiratory infection treated with moxifloxacin hydrochloride. Chinese Journal of Modern Practical Medicine, 2007, 6: 10-11. Chen Yong. Research progress and analysis of pharmacological properties and drug safety of moxifloxacin. Chinese Medicine Guide, 2011, 9: 186...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D471/04
CPCC07D471/04
Inventor 张伟苗郁陈改荣王凯凯陈爱敏
Owner XINXIANG UNIV